Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.
Also called NCT02391779
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02391779
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02391779. Randomized; double masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2017-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension
- Condition
- Hypertension
- Intervention (Dietary supplement)
- BeneFlax®
- Intervention (Behavioral)
- Walking training
- Intervention (Behavioral)
- Flexibility training
- Intervention (Dietary supplement)
- Placebo (Whey Protein)
- Intervention (Behavioral)
- Dash Eating Plan
- Lead sponsor
- University of Saskatchewan
Record details
- Record id
cardio:ct-nct02391779- Content hash
ceba3246c46d0a08aeb5a82636da4dd7b9ae07254c439f51aba22f5c92e7d1e6